Indefinite Delivery Contract 36C26323D0087
Award Date
5/1/23
Last Date to Order
4/30/28
Federal Agency
Veterans Integrated Service Network 23
Awardee
Veracyte, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award, valued at up to $890,640.00, was issued by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 16 (VISN 16) to Veracyte, Inc., a for-profit provider of genomic testing services. The single-award IDV, awarded on October 1, 2024 with a potential completion date of September 30, 2029, will enable VISN 16 to efficiently access Veracyte's commercial laboratory capabilities for specialized pathology testing to support VA hospitals and clinics...
The federal contract IDV award to Veracyte, Inc. under the GSA's Medical Laboratory Testing and Analysis Services Schedule (FSS-621-II) enables multiple federal agencies, including the Department of Veterans Affairs (VA) and Defense Health Agency, to procure Veracyte's genomic testing services. The contract, valued at up to $2.3 million through July 2028, provides access to Veracyte's commercial laboratory capabilities for cancer screening and diagnosis, such as the Afirma Genomic Sequencing...
The federal contract IDV award is for Decipher Prostate Genomic Classifier testing services provided by Veracyte Labs SD Corporation, a division of Veracyte, Inc., to the Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract has a ceiling value of $194,435.40 and a period of performance through September 30, 2026. Under this IDV, Veracyte will deliver task orders for Decipher Prostate Cancer testing to support the VA's efforts to provide personalized cancer care...
The key products and services being delivered under this federal contract IDV award are specialized genomic testing services, primarily focused on prostate cancer diagnostics and treatment planning. The prime contractor, Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., provides its proprietary Decipher Prostate Cancer Test and other advanced molecular diagnostic capabilities to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Networks (VISNs)...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery, indefinite quantity contract to Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc., with a potential value of $249,000.00 and a period of performance through September 30, 2023. Against this contract, the agency issued four firm fixed price delivery orders for prostate cancer testing services. The orders called for providing the proprietary...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the provision of Decipher Prostate Cancer Testing services. This contract, valued at up to $991,815.95, is established under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not have a set-aside designation. The contract aims to support the VA's efforts to provide personalized,...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 8 awarded a $972,177 Blanket Purchase Agreement (BPA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., to provide Decipher Prostate Cancer genomic testing services. This single-award IDV contract, utilizing the GSA Medical Laboratory Testing and Analysis Services Schedule, enables VISN 8 facilities to efficiently access Decipher's proprietary molecular diagnostic tests to support...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Network Contracting Office (NCO) 21, to Diacarta, Inc. for reference laboratory testing services to aid in the diagnosis of VEXAS Syndrome. The contract has a total ceiling value of $200,000 and a period of performance from October 1, 2024 to September 30, 2029. The key services under this contract include specimen pickup, testing for somatic mutations of the UBA1 gene, reporting, and consultation....
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 and Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $3,426,923.40 and a period of performance extending to June 30, 2029. Under this IDC, Cepheid will provide the VA with a reagent lease for its molecular diagnostic testing equipment and associated...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $5,000,000.00 and a period of performance through September 30, 2028. Under this IDC, Cepheid is providing its molecular testing products, including the GeneXpert diagnostic system and associated reagents, test kits, and consumables, to...